Lichtenfels, M. (2026) “What happens in residual disease after neoadjuvant chemotherapy? Efficacy of a novel in vitro breast cancer chemoresistance platform to demonstrate high resistance to drugs”, Mastology. Rio de Janeiro, 33(suppl.1). doi: 10.29289/259453942023V33S1010.